Roche Pharmaceuticals A/S: Financial statements 2024
CVR: 25230515
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 826,964,000 and a net result of DKK 24,277,000 compared with DKK 36,536,000 the year before. That is an increase of 8.6% compared with the year before. The profit margin was 2.9%. Equity in the 2024 report amounted to DKK 163,860,000. The solvency ratio was 46.1%. The company had 96 employees in the financial year.
- Revenue
- DKK 826,964,000
- Gross Profit
- DKK 126,671,000
- Profit/Loss
- DKK 24,277,000
- Equity
- DKK 163,860,000
- Total Assets
- DKK 355,290,000
- Employees
- 96
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 827M | 126.7M | 24.3M | 163.9M | 96 |
| 2023 | 761.4M | 145.1M | 36.5M | 139.6M | 97 |
| 2022 | 785.6M | 149.1M | 19.6M | 163M | 103 |
| 2021 | 732.8M | 133M | 16.3M | 143.5M | 110 |
| 2020 | 701.9M | 126.9M | 12.3M | 127.2M | 121 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.164.a" issued by Amgros I/S worth 1,344,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 2.703.b" issued by Amgros I/S worth 183,298,522 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.180.a" issued by Amgros I/S worth 69,160,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2025 1.175.a" issued by Amgros I/S worth 666,000,000 DKK.
Roche Pharmaceuticals A/S has published its annual report for 2023. Revenue came to DKK 761,417,000, and the net result was DKK 36,536,000.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.976.a" issued by Amgros I/S worth 15,470,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.167.a" issued by Amgros I/S worth 291,550,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.352.b" issued by Amgros I/S worth 243,000,000 DKK.
Roche Pharmaceuticals A/S has won the tender "Amgros 2024 1.176.a" issued by Amgros I/S worth 157,309,680 DKK.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.